59 Biotech Startups in Paris to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Developer of a universal AI foundation model for biology. |
$35M · Seed | Frst, Bpifrance, Sofinnova Partners | 1 to 10 | AI, Biotech | B2B, SaaS | Paris, France | •••••••••••@bioptimus.com | |
Immunotherapies developer for cancer patient. |
$4M · Seed | Fournier-Majoie, France 2030, Elaia | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@hephaistos-pharma.fr | ||
Gene-editing platform. |
$30M · Series B | Khosla Ventures, Sanofi Ventures, Bpifrance | 11 to 50 | Health Tech, Biotech | Paris, France | •••••••••••@eligo.bio | ||
Drug discovery platform. |
$32M · Series A | Wendel Growth, Bpifrance, Elaia | 51 to 100 | Biotech | B2B | Paris, France | •••••••••••@aqemia.com | |
Cancer survivors data analysis platform. |
$16M · Seed | Hitachi Ventures, Life Extension Ventures, Sofinnova Partners | 11 to 50 | Biotech, Data and Analytics | B2B, SaaS | Paris, France | •••••••••••@cure51.com | |
Point-of-care diagnostic platform. |
$1M · Pre Seed | CentraleSupélec Venture | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@encarta.bio | ||
Biosensors developer to combat chronic kidney disease. |
$2M · Pre Seed | Bpifrance, Kima Ventures, Cenitz | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@metyos.com | ||
Biotechnology company focused on developing genomic medicines to treat blinding inherited retinal diseases. |
$52M · Series A | Ysios Capital | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Paris, France | •••••••••••@sparingvision.com | |
Biotechnology firm focused on life science advancements. |
$89M · Series A | Sofinnova Partners | 101 to 250 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@mnemo-tx.com | |
Eco-friendly liquid-liquid direct lithium extraction (DLE) process developer. |
$27M · Series B | Bpifrance, Celeste Management, Sociedad Quimica Y Minera (SQM) | 11 to 50 | Climate Tech & Green Tech, Biotech | B2B | Paris, France | •••••••••••@adionics.com | |
Automated bioprocessing system for the production of cell and gene therapies. |
$18M · Seed | AdBio Partners | 11 to 50 | Biotech | Paris, France | •••••••••••@astraveus.com | ||
Biotechnology firm developing immunotherapies for cancer and autoimmune diseases. |
$46M | Bioqube Ventures | 11 to 50 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@egle-tx.com | |
Biomanufacturer of complex molecules. |
$4M · Seed | Meusinvest (Noshaq) | 1 to 10 | Biotech, Manufacturing | Paris, France | •••••••••••@samabriva.com | ||
Platform that develops bio factories to treat significant eye diseases sustainably. |
$30M · Series B | Karista, Pureos Bioventures | 11 to 50 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@eyevensys.com | |
Medical devices for a transvascular treatment of pulmonary hypertension. |
$14M · Series A | Sofinnova Partners, Asabys Partners | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@gradientdenervation.com | ||
Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases. |
$3M · Series F | The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Paris, France | •••••••••••@enterome.com | |
Biotech firm developing treatments for auto-immune diseases. |
$6M · Series A | Fountain Healthcare Partners | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Paris, France | •••••••••••@ermium.com | |
Technology transforming large-scale protein production for sustainability. |
$11M · Series A | Blue Oceans Partners | 11 to 50 | Climate Tech & Green Tech, Agritech, Foodtech, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@nextprotein.co | |
Biotech solution providing NGS-based metagenomic tests to fully identify pathogens. |
$8M | Eurazeo, Norgine Ventures, Verve Ventures | 11 to 50 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@pathoquest.com | |
Petroleum-free pigments. |
$15M · Series A | Bpifrance, Elaia | 11 to 50 | Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing | B2B | Paris, France | •••••••••••@pili.bio | |
Platform that accelerates drug discovery using advanced computational techniques. |
$17M · Seed | Quantonation, XAnge | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@qubit-pharmaceuticals.com | |
Biotechnology company based in Paris, focusing on innovative genetic analysis solutions. |
$12M | Eurazeo | 11 to 50 | Health Tech, Biotech, Genetics | B2B | Paris, France | •••••••••••@stillatechnologies.com | |
Niodegradable sealants and adhesives for wound closure. |
$8M · Series A | Bpifrance, CM-CIC Capital Finance, Sofinnova Partners | 51 to 100 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@tissium.com | |
Solution for storing large amounts of computer data on long DNA strands at a low cost. |
$5M | Bpifrance | 1 to 10 | Health Tech, Biotech, Data and Analytics, Business Intelligence | Paris, France | •••••••••••@biomemory-labs.com | ||
Protein-based vaccines. |
$7M · Series A | In-Q-Tel | 1 to 10 | Biotech | Paris, France | •••••••••••@linkinvax.com | ||
AI-dirven clinical biology. |
$14M · Series A | Sofinnova Partners | 11 to 50 | Biotech | Paris, France | •••••••••••@kiro.bio | ||
Interceptive therapies for heart failure subpopulations. |
$12M · Seed | OrbiMed, Invivo Capital Partners, Omnes Capital | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@corteriapharma.com | ||
Developer of biotherapeutic products to treat cancer. |
$3M · Debt Financing | Bpifrance | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@everimmune.net | ||
Breast milk producer from cell-cultured mammary glands. |
$3M · Pre Seed | Heartcore, Kima Ventures, Kost Capital | 1 to 10 | Biotech, FamilyTech & Parenting | B2C | Paris, France | •••••••••••@numi.life | |
PCOS infertility treatment developer. |
$10M · Series A | Bpifrance, Avestria Ventures, Trill Impact | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@mayhealth.com | ||
Bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases |
$2M · Pre Seed | Elaia | 1 to 10 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@honing-biosciences.com | |
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1). |
$2M · Seed | Bpifrance, Idinvest Partners, AGORANOV | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Paris, France | •••••••••••@step-ph.com | |
Biotechnology platform developing advanced recombinant protein production technologies. |
$3M · Seed | Entrepreneur First, Thia Ventures, XAnge | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing | B2B | Paris, France | •••••••••••@corebiogenesis.com | |
Non-GMO breeding platform. |
$1M · Pre Seed | PINC, Exceptional Ventures, Joyance Partners | 1 to 10 | Agritech, Biotech | B2B | Paris, France | •••••••••••@amatera.bio | |
AI to detect congenital heart defects in fetuses. |
$2M · Seed | Sofinnova Partners | 1 to 10 | AI, Biotech | Paris, France | •••••••••••@brightheart.fr | ||
AI-driven high-dimensional immune system analysis platform. |
$2M · Pre Seed | Kima Ventures, Eurazeo, Boutique Venture Partners | 1 to 10 | AI, Biotech | B2B, SaaS | Paris, France | •••••••••••@surge.care | |
PLANT-BASED MARINE SUBSTITUTES WITH ALGAE INGREDIENTS. FOR NATURAL, HEALTHY, SUSTAINABLE FOOD |
$3M · Pre Seed | Founders Future, Demeter Partners | 1 to 10 | Agritech, Foodtech, Biotech, Manufacturing | B2B, B2C | Paris, France | •••••••••••@seafood-reboot.com | |
Platform creating lab-grown alternatives to animal leather using synthetic biology and material science. |
$3M · Seed | Kindred Capital, Entrepreneur First | 1 to 10 | Climate Tech & Green Tech, Fashion, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@faircraft.bio | |
AI-powered data collecting tool for clinical trials. |
$1M · Seed | Kima Ventures, Cathay Innovation, Serena | 11 to 50 | Health Tech, AI, Biotech, Machine Learning, Pharma | B2B, SaaS | Paris, France | •••••••••••@inato.com | |
Monitoring system for biological and chemical analysis using integrated photonics. |
$573k · Pre Seed | Quantonation | 1 to 10 | Biotech, Data and Analytics, Robotics, Navigation and Mapping, Manufacturing, Business Intelligence | B2B | Paris, France | •••••••••••@inspek-solutions.com | |
Gene therapies for rare diseases. |
$490k · Seed | Bpifrance, Idinvest Partners, Omnes Capital | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Paris, France | •••••••••••@coavetx.com | |
Platform for gene and cell therapy companies to develop cheaper drugs faster using digital tools. |
$500k · Pre Seed | Y Combinator | 11 to 50 | Health Tech, Biotech, Genetics, Business Intelligence | B2B, SaaS | Paris, France | •••••••••••@whitelabgx.com | |
Biotech firm producing insect-based protein for animal feed. |
$250M · Series D | 101 to 250 | Biotech, Deep Tech | Paris, France | •••••••••••@innovafeed.com | |||
International advisory firm for healthcare sector. |
$58M · Series C | 101 to 250 | Health Tech, Biotech | Paris, France | •••••••••••@alirahealth.com | |||
Biotechnology company focused on developing gene therapies for neurological disorders. |
N/A | Pureos Bioventures | 11 to 50 | Health Tech, Biotech | B2B | Paris, France | •••••••••••@corlieve.com | |
Topical treatments for complex pain. |
$21M · Series B | 1 to 10 | Health Tech, Biotech | Paris, France | •••••••••••@algotx.com | |||
Platform that uses deep learning on multi-omics data to model cells and efficiently engineer their behavior. |
N/A | Kima Ventures, Entrepreneur First | 1 to 10 | Health Tech, AI, Biotech, Machine Learning | B2B | Paris, France | •••••••••••@trydeeplife.org | |
Genetic analysis technology for decoding the dynamic genome. |
$35M · Series A | 11 to 50 | Health Tech, Biotech, Manufacturing, Genetics | B2B | Paris, France | •••••••••••@depixus.com | ||
Houseplants developer to remove harmful air pollutants. |
N/A | Heartcore, Entrepreneur First, True Ventures | 11 to 50 | Agritech, Biotech | B2C | Paris, France | •••••••••••@neoplants.co | |
Developing pinpoint gene therapy. |
$5M · Series A | 11 to 50 | Health Tech, Biotech | B2C | Paris, France | •••••••••••@eg427.com | ||
Imaging technology for quick and non-invasive skin cancer detection. |
$5M · Series A | 11 to 50 | Health Tech, Hardware, Biotech, Business Intelligence | B2B, SaaS | Paris, France | •••••••••••@damae-medical.com | ||
Therapeutic tools for treating cancer. |
$5M · Series A | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@everimmune.com | ||
Biotech firm specializing in the production of rapid biosensing devices like the CHRONOS PCR. |
$2M · Seed | 11 to 50 | Health Tech, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@bforcure.com | ||
Platform combining MRI scans and AI to produce rapid, actionable insights into central nervous system disorders. |
$2M · Seed | 11 to 50 | Health Tech, AI, Biotech, Deep Tech, Machine Learning, Data and Analytics | B2B, SaaS | Paris, France | •••••••••••@qynapse.com | ||
Biotechnology company in France focused on developing plant-based solutions for various industries. |
$644k · Seed | 1 to 10 | Health Tech, Foodtech, Biotech, Energy & Nuclear, Manufacturing | B2B | Paris, France | •••••••••••@alkinnov.com | ||
Biotech company providing large-scale GMP manufacturing of extracellular vesicles for nanomedicine. |
$1M | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Paris, France | •••••••••••@everzom.com | ||
Recycling system that transforms eggshells into calcium carbonate powder and shell membrane powder. |
$1M | 1 to 10 | Climate Tech & Green Tech, Agritech, Foodtech, Fashion, Biotech, Manufacturing | B2B | Paris, France | •••••••••••@circulegg.fr | ||
Provider of minimally invasive solutions for treatment of tricuspid regurgitation |
$50M · Series D | 11 to 50 | Health Tech, Biotech | Paris, France | •••••••••••@tricares.com | |||
Preclinical biotech company developing technology for the treatment of eye diseases. |
$7M · Seed | Elaia, Go Capital, UI Investissement | 1 to 10 | Health Tech, Biotech | B2C | Paris, France | •••••••••••@biophta.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.